Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended-cycle versus standard oral contraceptives on hemostatic parameters in healthy women
2010-023215-34Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of avatrombopag, ethinyl estradiol and desogestrel in contraception (3 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Change from baseline in prothrombin fragment 1+2. Started Dec 2010; status: completed.
02
Drugs
avatrombopagethinyl estradioldesogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2010-023215-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023215-34.